Related Experiment Video
Updated: Mar 29, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Abstract:
Occasionally, pregnant women are inadvertently vaccinated against human papillomavirus. Data are available able on pregnancy outcomes in over a thousand women exposed to the HPV 6/11/16/18 vaccine and several hundred exposed to the HPV 16/18 vaccine. No notable risks were identified. No specific safety signals have been identified with the aluminium- and lipid-containing adjuvant AS04 included in the HPV 16/18 vaccine, nor with the aluminium-based adjuvant used in the HPV 6/11/16/18 vaccine.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mitral Valve Prolapse III: Nursing Management
Teratogenicity
Vaccinations
Birth Control Methods
Sexually Transmitted Infections

